CymitQuimica logo

1-tert-butyl-4,4-Diphenyl-piperidine

CAS:

Ref. 3D-FB156517

10mg
Discontinued
25mg
Discontinued
50mg
Discontinued
100mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

1-tert-butyl-4,4-Diphenyl-piperidine
Biosynth

Product Information

Name:1-tert-butyl-4,4-Diphenyl-piperidine
Synonyms:
  • Budipine
Brand:Biosynth
Description:1-tert-butyl-4,4-Diphenyl-piperidine is a drug that binds to the dopamine D2 receptor. It inhibits locomotor activity in animals and has been shown to be neurotoxic in vivo. 1-tert-butyl-4,4-Diphenyl-piperidine has been shown to exhibit antioxidative properties, which may be due to its ability to scavenge reactive oxygen species (ROS) or inhibit lipid peroxidation. This drug also has antimuscarinic effects and is used as an antiparkinsonian agent. It is a competitive antagonist at the muscarinic M1 receptor and displays high affinity for the dopamine D2 receptor in vitro. Moreover, it increases striatal dopamine concentrations in vivo and exhibits antiparkinsonian effects when administered intraperitoneally to rats. Fatty acid metabolism is inhibited by this drug, which may lead to an increase in endogenous substances such as gamma-aminob
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:293.45 g/mol
Formula:C21H27N
Purity:Min. 95%
Color/Form:Powder
InChI:InChI=1S/C21H27N/c1-20(2,3)22-16-14-21(15-17-22,18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13H,14-17H2,1-3H3
InChI key:InChIKey=QIHLUZAFSSMXHQ-UHFFFAOYSA-N
SMILES:CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1

Inquiry about discontinued product: 1-tert-butyl-4,4-Diphenyl-piperidine

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.